Health-Related Quality of Life in Movement Disorders

  • R. Dodel
  • A. Schrag
Reference work entry


This paper reviews the literature on health status and quality of life (QOL) in patients with movement disorders with a focus on the following diseases:  Parkinson’s disease, atypical Parkinsonism ( multiple system atrophy,  progressive supranuclear palsy,  dementia with Lewy bodies),  Huntington’s disease and  Restless Legs Syndrome.

Several disease-specific instruments are currently available for the different movement disorders. For Parkinson’s disease, 8 different scales have been developed and almost all focus primarily on the health status of the patient. Parkinson’s disease is associated with reduced health status, including motor and non-motor physical complications of the disease, emotional well-being and social functioning. Although the impact is greater in advanced stages of Parkinson’s disease, there is no close relationship between disease duration and impact on health status. Occurrence and severity of depression, however, correlates notably with health status scores, and a number of studies have found depression to be one of the primary determinants of poor health status.

In atypical Parkinsonism specific, validated instruments exist for multiple system atrophy and progressive supranuclear palsy. A considerable reduction in health status scores was reported for all patients suffering from atypical Parkinsonism and health status appeared to be impaired more severely than in Parkinson’s disease after the same disease duration. In dementia with Lewy bodies, health status is affected more severely than in matched patients with Alzheimer’s disease.

Condition-specific instruments have been developed and validated for health status assessment in both patients with Huntington’s disease and their caregivers. The impact of Huntington’s disease on quality of life is considerable and not only limited to affected patients but also affects their families, particularly family members who may be carrying the gene, as well as caregivers of patients. In restless legs syndrome, several disease-specific instruments are currently available and have been used in clinical trails. Health status is markedly reduced in patients with restless legs syndrome and is affected to a similar extent as in patients with Parkinson’s disease.

Although the evaluation of alternative outcomes in movement disorders has emerged in recent years, many questions have not been addressed and thus require further research.


Movement Disorder Multiple System Atrophy Lewy Body Dementia With Lewy Body Progressive Supranuclear Palsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:


15D questionnaire




EuroQOL visual analogue scale


Health-related quality of life


Health Utility Index


multiple system atrophy


Nottingham Health Profile


Parkinson’s disease questionnaire 39-item version


Parkinson’s Disease Questionnaire 8-item version


Parkinson’s Disease Quality of Life questionnaire


Parkinson’s Disease Quality of Life


Parkinson’s Disease Symptom Inventory


Parkinson’s Impact Scale


Parkinson Lebensqualität


Progressive supranuclear palsy


Quality of Life Index


Quality of life with DBS


quality of life


Restless legs syndrome quality of life instrument


Restless legs syndrome quality of life


Scales for Outcomes in Parkinson’s disease


Schedule for the Evaluation of Individual Quality of Life - Direct Weighting

SF 36

Short Form Health Survey


Sickness Impact Profile


Unified Parkinson’s Disease Rating Scale


World Health Organization Quality of Life assessment instrument


  1. Abele M, Klockgether T. (2007). Mov Disord. 22: 348–352.PubMedCrossRefGoogle Scholar
  2. Abetz L, Allen R, Follet A, Washburn T, Earley C, Kirsch J, Knight H. (2004). Clin Ther. 26: 925–935.PubMedCrossRefGoogle Scholar
  3. Abetz L, Arbuckle R, Allen RP, Mavraki E, Kirsch J. (2005). Health Qual Life Outcomes. 3: 79–90.PubMedCrossRefGoogle Scholar
  4. Atkinson MJ, Allen RP, DuChane J, Murray C, Kushida C, Roth T. (2004). Qual Life Res. 13: 679–693.PubMedCrossRefGoogle Scholar
  5. Aubeeluck A, Buchanan H. (2007). Clin Genet. 71: 434–445.PubMedCrossRefGoogle Scholar
  6. Baas HK, Schueler P. (2001). Eur Neurol 46 Suppl. 1: 18–23.PubMedCrossRefGoogle Scholar
  7. Benrud-Larson LM, Sandroni P, Schrag A, Low PA. (2005). Mov Disord. 20: 951–957.PubMedCrossRefGoogle Scholar
  8. Boström F, Jönsson L, Minthon L, Londos E. (2007). Alzheimer Dis Assoc Disord. 21: 150–154.PubMedCrossRefGoogle Scholar
  9. Camfield L, Ben-Shlomo Y, Warner TT. (2002). Mov Disord 17: 838–841.PubMedCrossRefGoogle Scholar
  10. Carod-Artal FJ, Vargas AP, Martinez-Martin P. (2007). Mov Disord. 22: 1408–1415.PubMedCrossRefGoogle Scholar
  11. Chapuis S, Ouchchane L, Metz O, Gerbaud L, Durif F. (2005). Mov Disord. 20: 224–230.PubMedCrossRefGoogle Scholar
  12. Den Oudsten BL, Van Heck GL, De Vries J. (2007). Mov Disord. 22: 1528–1537.PubMedCrossRefGoogle Scholar
  13. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M, Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM, Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A, Schneider GH, Schnitzler A, Steude U, Sturm V, Timmermann L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voges J. (2006). N Engl J Med. 355: 896–908.PubMedCrossRefGoogle Scholar
  14. Elstner K, Selai CE, Trimble MR, Robertson MM. (2001). Acta Psychiatr Scand 103: 52–59.PubMedCrossRefGoogle Scholar
  15. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, et al. (2007). Mov Disord 22: 1689–1707.PubMedCrossRefGoogle Scholar
  16. Evers-Kiebooms G, Decruyenaere M. (1998). Patient Educ Couns. 35: 15–26.PubMedCrossRefGoogle Scholar
  17. Gerhard R, Bosse A, Uzun D, Orth M, Kotterba S. (2005). Med Klin (Munich). 100: 704–709.CrossRefGoogle Scholar
  18. Gerschlager W, Schrag A, Brown P. (2002). Mov Disord. 17: 1064–1067.PubMedCrossRefGoogle Scholar
  19. Global Parkinson’s Disease Survey Steering Committee. (2002). Mov Disord. 17: 60–67.Google Scholar
  20. Gomez-Esteban JC, Zarranz JJ, Lezcano E, Tijero B, Luna A, Velasco F, Rouco I, Garamendi I. (2007). Eur Neurol. 57: 161–165.PubMedCrossRefGoogle Scholar
  21. Gronchi-Perrin A, Viollier S, Ghika J, Combremont P, Villemure JG, Bogousslavsky J, Burkhard PR, Vingerhoets F. (2006). Mov Disord 21: 1465–1468.PubMedCrossRefGoogle Scholar
  22. Happe S, Reese JP, Stiasny-Kolster K, Peglau I, Mayer G, Klotsche J, Giani G, Geraedts M, Trenkwalder C, Dodel R. (2008). Sleep Med doi: 10.1016/j.sleep.2008.01.002.Google Scholar
  23. Helder DI, Kaptein AA, Van Kempen GM, Weinman J, Van Houwelingen HC, Roos RA. (2002). Br J Health Psychol. 7: 449–462.PubMedCrossRefGoogle Scholar
  24. Ho AK, Robbins AO, Walters SJ, Kaptoge S, Sahakian BJ, Barker RA. (2004). Mov Disord. 19: 1341–1348.PubMedCrossRefGoogle Scholar
  25. Hobson P, Holden A, Meara J. (1999). Age Ageing. 28: 341–346.PubMedCrossRefGoogle Scholar
  26. Jain S, Dawson J, Quinn NP, Playford ED. (2004). Mov Disord. 19: 1360–1364.PubMedCrossRefGoogle Scholar
  27. Karlsen KH, Larsen JP, Tandberg E, Maeland JG. (1999). J Neurol Neurosurg Psychiatry. 66: 431–435.PubMedCrossRefGoogle Scholar
  28. Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE, Deuschl G. (2006). Mov Disord 21 Suppl. 14: S290–S304.PubMedCrossRefGoogle Scholar
  29. Kohnen R, Benes H, Kurella B. (2002). Mov Disord. 17: P743.CrossRefGoogle Scholar
  30. Koller W, Lees A, Doder M, Hely M. (2001). Mov Disord. 16: 858–866.PubMedCrossRefGoogle Scholar
  31. König HH, Bernert S, Angermeyer MC. (2005). Gesundheitswesen 67: 173–182.PubMedCrossRefGoogle Scholar
  32. Kuopio AM, Marttila RJ, Helenius H, Toivonen M, Rinne UK. (2000). Mov Disord. 15: 216–223.PubMedCrossRefGoogle Scholar
  33. Kushida C, Martin M, Nikam P, Blaisdell B, Wallenstein G, Ferini-Strambi L, Ware JE Jr. (2007). Qual Life Res. 16: 617–624.PubMedCrossRefGoogle Scholar
  34. Kushida CA, Allen RP, Atkinson MJ. (2004). Sleep Med. 5: 485–488.PubMedCrossRefGoogle Scholar
  35. Lopez-Bastida J, Perestelo-Perez L, Monton-Alvarez F, Serrano-Aguilar P. (2008). Mov Disord. 23: 212–217.PubMedCrossRefGoogle Scholar
  36. Lorenz D, Schwieger D, Moises H, Deuschl G. (2006). Mov Disord. 21: 1114–1118.PubMedCrossRefGoogle Scholar
  37. Marinus J, Ramaker C, van Hilten JJ, Stiggelbout AM. (2002). J Neurol Neurosurg Psychiatry. 72: 241–248.PubMedCrossRefGoogle Scholar
  38. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, et al. (2005). Neurology 65: 1863–1872.PubMedCrossRefGoogle Scholar
  39. Moore AP, Lloyd A, Scott DA, Connolly M, Dixon S. (2004). Value in Health. 7: 791.CrossRefGoogle Scholar
  40. Noyes K, Dick AW, Holloway RG. (2006). Value Health 9: 28–38.PubMedCrossRefGoogle Scholar
  41. O’Connor EJ, McCabe MP, Firth L. (2008). J Sex Marital Ther. 34: 115–132.PubMedCrossRefGoogle Scholar
  42. Reese J, Stiasny-Kolster K, Oertel W, Dodel R. (2007).Google Scholar
  43. Reuther M, Spottke EA, Klotsche J, Riedel O, Peter H, Berger K, Athen O, Kohne-Volland R, Dodel RC. (2007). Parkinsonism Relat Disord. 13: 108–114.PubMedCrossRefGoogle Scholar
  44. Riedemann C, Zerr I, Kropp S, Otto A, Poser S, Herrmann C. (1999). Z Psychosom Med Psychother. 45: 128–141.PubMedGoogle Scholar
  45. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. (2000). Neurology. 54: 1064–1068.PubMedGoogle Scholar
  46. Saletu M, Anderer P, Hogl B, Saletu-Zyhlarz G, Kunz A, Poewe W, Saletu B. (2003). J Neural Transm. 110: 611–626.PubMedCrossRefGoogle Scholar
  47. Schrag A, Geser F, Stampfer-Kountchev M, Seppi K, Sawires M, Köllensperger M, Scherfler C, Quinn N, Pellecchia MT, Barone P, Del Sorbo F, Albanese A, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Nilsson CF, Widner H, Lindvall O, Giladi N, Gurevich T, Daniels C, Deuschl G, Coelho M, Sampaio C, Abele M, Klockgether T, Schimke N, Eggert KM, Oertel W, Djaldetti R, Colosimo C, Meco G, Poewe W, GK; W, Group. EM-S. (2006). Mov Disord. 21: 809–815.PubMedCrossRefGoogle Scholar
  48. Schrag A. Jahanshahi M, Quinn N. (2000). J Neurol Neurosurg Psychiatry. 69: 308–312.PubMedCrossRefGoogle Scholar
  49. Schrag A, Selai C, Davis J, Lees AJ, Jahanshahi M, Quinn N. (2003). Mov Disord. 18: 1464–1469.PubMedCrossRefGoogle Scholar
  50. Schrag A, Selai C, Mathias C, Low P, Hobart J, Brady N, Quinn NP. (2007). Mov Disord. 22: 2332–2338.PubMedCrossRefGoogle Scholar
  51. Schrag A, Selai C, Quinn N, Lees A, Litvan I, Lang A, Poon Y, Bower J, Burn D, Hobart J. (2006). Neurology. 67: 39–44.PubMedCrossRefGoogle Scholar
  52. Slawek J, Derejko M, Lass P. (2005). Parkinsonism Relat Disord. 11: 465–468.PubMedCrossRefGoogle Scholar
  53. Slawek J, Friedman A, Potulska A, Krystkowiak P, Gervais C, Banach M, Ochudlo S, Budrewicz S, Reclawowicz D, Rynkowski M, Opala G. (2007). Funct Neurol. 22: 95–100.PubMedGoogle Scholar
  54. Storch EA, Merlo LJ, Lack C, Milsom VA, Geffken GR, Goodman WK, Murphy TK. (2007). J Clin Child Adolesc Psychol. 36: 217–227.PubMedCrossRefGoogle Scholar
  55. Sutcliffe RP, Maguire DD, Muiesan P, Dhawan A, Mieli-Vergani G, O’Grady JG, Rela M, Heaton ND. (2003). Transplantation. 75: 1003–1006.PubMedCrossRefGoogle Scholar
  56. von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K, Dodel R. (2005). Eur Neuropsychopharmacol 15: 473–490.PubMedCrossRefGoogle Scholar
  57. Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. (2004). J Am Geriatr Soc. 52: 784–788.PubMedCrossRefGoogle Scholar
  58. Zaccai J, McCracken C, Brayne C. (2005). Age Ageing. 34: 561–566.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • R. Dodel
    • 1
  • A. Schrag
    • 2
  1. 1.Department of NeurologyPhilipps-University MarburgMarburgGermany
  2. 2.University Department of Clinical NeurosciencesRoyal Free and University College Medical SchoolLondonUK

Personalised recommendations